Anti-Ro52 antibody is highly prevalent and a marker of better prognosis in patients with ovarian cancer
- Resource Type
- Article
- Authors
- Bogdanos, Dimitrios P.; Gkoutzourelas, Athanasios; Papadopoulos, Vasilios; Liaskos, Christos; Patrikiou, Eleni; Tsigalou, Christina; Saratziotis, Athanasios; Hajiioannou, John; Scheper, Thomas; Meyer, Wolfgang; Sakkas, Lazaros I.; Papandreou, Christos
- Source
- In Clinica Chimica Acta October 2021 521:199-205
- Subject
- Language
- ISSN
- 0009-8981